HomeCompareIAALF vs MRK

IAALF vs MRK: Dividend Comparison 2026

IAALF yields 1333.33% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IAALF wins by $241528700.55M in total portfolio value
10 years
IAALF
IAALF
● Live price
1333.33%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$241528700.61M
Annual income
$210,475,860,072,406.56
Full IAALF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — IAALF vs MRK

📍 IAALF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIAALFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IAALF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IAALF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IAALF
Annual income on $10K today (after 15% tax)
$113,333.33/yr
After 10yr DRIP, annual income (after tax)
$178,904,481,061,545.56/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, IAALF beats the other by $178,904,481,053,217.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IAALF + MRK for your $10,000?

IAALF: 50%MRK: 50%
100% MRK50/50100% IAALF
Portfolio after 10yr
$120764350.33M
Annual income
$105,237,930,041,102.34/yr
Blended yield
87.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IAALF
No analyst data
Altman Z
-3.8
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IAALF buys
0
MRK buys
0
No recent congressional trades found for IAALF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIAALFMRK
Forward yield1333.33%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$241528700.61M$56.8K
Annual income after 10y$210,475,860,072,406.56$9,798.13
Total dividends collected$239239876.27M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IAALF vs MRK ($10,000, DRIP)

YearIAALF PortfolioIAALF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$144,033$133,333.33$11,206$366.19+$132.8KIAALF
2$1,948,924$1,794,807.89$12,650$502.35+$1.94MIAALF
3$24,782,219$22,696,870.86$14,407$694.19+$24.77MIAALF
4$296,245,945$269,728,970.81$16,585$967.82+$296.23MIAALF
5$3,330,378,004$3,013,394,842.54$19,342$1,363.89+$3330.36MIAALF
6$35,223,684,321$31,660,179,856.69$22,913$1,947.19+$35223.66MIAALF
7$350,636,384,108$312,947,041,885.16$27,662$2,823.89+$350636.36MIAALF
8$3,286,630,500,315$2,911,449,569,318.85$34,159$4,173.35+$3286630.47MIAALF
9$29,021,346,295,663$25,504,651,660,325.88$43,337$6,308.80+$29021346.25MIAALF
10$241,528,700,608,766$210,475,860,072,406.56$56,776$9,798.13+$241528700.55MIAALF

IAALF vs MRK: Complete Analysis 2026

IAALFStock

IBC Advanced Alloys Corp. develops, produces, and sells specialty alloy products in the United States and internationally. The company operates through Copper Alloys and Engineered Materials segments. It offers various copper alloys as castings and forgings, including beryllium copper, chrome copper, oxygen-free high conductivity copper, and aluminum bronze in the form of plates, blocks, bars, and rings, as well as specialty copper alloy forgings for industrial welding, oil and gas, plastic mold, metal melting, marine defense, electronic, and industrial equipment markets. The company also provides tooling components for the automotive industry, consumer plastic tooling producers, oil and gas service industry, submarine and aircraft carrier producers and repair facilities, electronics industries, and general equipment manufacturers. In addition, it manufactures and supplies precision-cast beryllium-aluminum components to defense, aerospace, high-tech manufacturing, and other sectors. The company was formerly known as International Beryllium Corporation and changed its name to IBC Advanced Alloys Corp. in March 2009. The company was incorporated in 2002 and is headquartered in Franklin, Indiana.

Full IAALF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IAALF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IAALF vs SCHDIAALF vs JEPIIAALF vs OIAALF vs KOIAALF vs MAINIAALF vs JNJIAALF vs ABBVIAALF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.